ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31

ACCENDRA HEALTH INC/VA/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$0.22−0.01 (-6.30%)

Close on Oct 19, 2026

Market cap: $16.89M
P/E (TTM): –
Dividend yield: –

ACCENDRA HEALTH INC/VA/ cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Depreciation & Amortization	215	181	210	229	91	93	117	102	59	55	66	63	51	40	34	29	25	22
Stock-Based Compensation	13	17	14	21	25	20	16	16	12	12	11	8.21	6.38	5.70	5.67	6.36	7.04	7.56
Deferred Income Taxes	-18	-8.04	-6.00	-26	-30	16	-17	-35	-50	4.22	-6.10	-3.39	3.71	1.06	15	-0.09	11	18
Other Non-Cash Items	-9.00	-7.61	-9.81	-12	-15	-6.87	-9.50	-6.04	-6.30	-3.66	-2.88	0.72	1.12	0.57	-1.24	0.60	1.37	–
Change in Inventory	-6.85	-4.59	-5.35	167	-263	-85	128	-65	-57	23	-70	-57	-7.06	59	-86	-41	-14	-56
Change in Accounts Payable	6.48	67	5.25	14	3.55	193	-236	92	144	43	114	-52	47	-19	44	-15	34	-14
Operating Cash Flow	-102	161	741	325	124	339	166	116	57	188	270	-3.76	141	219	68	143	218	63
Capital Expenditures	-191	-170	-172	-158	-41	-50	-42	-45	-35	-20	-21	-48	-28	-9.83	-25	-31	-20	-18
Acquisitions	-18	–	0	-1,685	0	0	0	-752	-367	0	0	-249	0	-155	0	–	–	–
Sale of Property, Plant & Equipment	78	70	72	48	0	0	0.33	1.69	0.66	5.38	0.14	0.16	3.05	3.30	2.43	3.93	4.08	0.41
Divestitures	342	–	–	0	0	133	0	–	–	–	–	–	–	–	–	–	–	–
Other Investing Activities	-1.91	15	-0.94	-1.67	-3.94	6.27	0.33	–	–	0	0	1.94	0	0	–	–	–	–
Investing Cash Flow	144	-117	-137	-1,804	-54	80	-52	-816	-417	-25	-36	-317	-57	-191	-34	-37	-21	-123
Dividends Paid	–	–	0	0	-0.73	-0.65	-5.23	-48	-63	-63	-64	-63	-61	-56	-51	-45	-38	-33
Share Repurchases	-10	–	–	–	–	–	–	0	-5.00	-71	-20	-9.93	-19	-15	-16	–	–	–
Stock Issued	–	–	–	0	0	190	0	–	–	–	–	–	–	–	–	–	–	–
Debt Issued	–	0	0	1,691	575	155	0	696	250	0	0	548	0	0	–	–	–	–
Debt Repaid	–	-244	-321	-4.50	-553	-617	-86	-16	-3.13	0	0	-217	0	0	–	–	–	–
Other Financing Activities	-3.12	-5.83	5.64	-43	-18	-16	-2.87	-7.22	-8.72	-8.29	-7.53	-7.31	-8.62	-2.71	-5.84	-2.77	-2.05	-3.27
Financing Cash Flow	188	-268	-417	1,497	-129	-379	-130	701	273	-143	-125	279	-82	-68	-58	-41	-182	65
Foreign Exchange Rate Adjustments	1.90	-0.90	0.61	-3.49	-3.54	9.91	-2.67	-1.99	6.10	4.22	-4.64	-2.68	2.52	2.73	0	–	–	–
Net Change in Cash	233	-224	187	14	-62	50	-19	-1.16	-81	24	104	-45	4.02	-38	-23	63	88	-2.51
Free Cash Flow	-293	-8.79	568	167	83	289	124	71	22	167	250	-52	112	209	43	112	198	45
Income Taxes Paid	12	5.55	-6.28	34	99	-17	-6.20	19	42	74	52	82	65	79	62	56	57	–
Interest Paid	135	142	153	107	39	90	95	69	31	28	28	19	15	15	14	14	13	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 44.8%
Operating margin: 1.1%
Net margin: -11.4%
Return on equity, FY2025: -1755.6%

Financial strength

Current ratio: 0.41
Debt to equity: -3.12
Debt to assets: 81.5%
Cash to current liabilities: 1.1%

Valuation

P/E ratio: –
Price to sales: 0.01
Price to book: –
Dividend yield: –